Researchers examined chronic opiate use, defined as 10 or more opiate dispensings over three or more months, or dispensing of 120 days of opiate supply during the year preceding bariatric surgery, both one year before and one year after surgery in approximately 12,000 patients who had undergone bariatric surgery between 2005 and 2009.
Approximately 8 percent of these patients were chronic opioid users.
Almost 80 percent of patients who were chronic opioid users before bariatric surgery continued using opiates to control their pain after the surgery and used more of the drugs after the surgery than preoperatively.
Researchers suggested pain management practices must improve for bariatric surgery patients known to be using opiates to control preoperative pain.
More Articles on Quality:
Study: Busy ICUs Have Higher Readmissions, But Not Mortality
HHS Invests Nearly $80M in Flu Vaccine, Burn Treatment
Limited Research Need Not Deter From Involving Patients in Hand Hygiene
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
